Fundz

Trait Biosciences Advances Innovative Water-Soluble Cannabinoid Technology, Delivering Key Milestones In Series A Financing And Appoints Dr. Hanny Kanafani As Vice President

PRIVATEDec 30, 2021

Round Type

Series A

Information TechnologyBiotechnologyCommunity And LifestyleHealth CareScience And Engineering

Description

Trait Biosciences Inc., a leading cannabinoid biotechnology research organization, announced that it has successfully completed key scientific studies and operational milestones associated with its Series A Financing, and said that Dr. Hanny Kanafani has been appointed to the newly created position of Vice President of Science Technology.

Quick answer

Trait Biosciences Inc. raised an undisclosed amount in a Series A round, dated December 30, 2021.

How much did Trait Biosciences Inc. raise?
Trait Biosciences Inc. raised an undisclosed amount in a Series A round on December 30, 2021.
What does Trait Biosciences Inc. do?
Trait Biosciences Inc. is a global leader in cannabinoid research, focused on developing technologies that enable the production of safe, high-quality, predictable, and efficacious CBD products.
Who are the decision-makers at Trait Biosciences Inc?
Fundz holds 1 contact at Trait Biosciences Inc., including the Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Community And Lifestyle and Science And Engineering around the same time

Companies in the same sectors as Trait Biosciences Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Arkuda Therapeutics raised $64M (Series B) on February 10, 2022.
  • Cargene raised $13M (Funding Round) on February 8, 2022.
  • Koneksa Health raised $45M (Series C) on February 7, 2022.
  • Dewpoint Therapeutics raised $150M on February 4, 2022.
  • Dewpoint Therapeutics raised $150M (Series C) on February 3, 2022.
  • Septerna raised $100M (Series A) on January 27, 2022.

Who to call at Trait Biosciences Inc., and when

A new round usually means Trait Biosciences Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Trait Biosciences Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Trait Biosciences Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Trait Biosciences Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Trait Biosciences Inc.

Location

480 - 1500 West Georgia St.

About

Trait Biosciences Inc. is a global leader in cannabinoid research, focused on developing technologies that enable the production of safe, high-quality, predictable, and efficacious CBD products. Our mission is to develop the world's most comprehensive integrated approach to cannabinoid science, insights, and technology. www.traitbio.com

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Trait Biosciences Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsGenise M., DirectorSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Trait Biosciences Inc.'s next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

Trait Biosciences Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.